Likes
Work life balance
Company name | Avg Annual Salary | Open Jobs |
---|---|---|
Sun Pharmaceutical Industries Machine Operator Salary
0 - 6 years exp. (21 salaries) | ₹1 L/yr - ₹3 L/yr
2%
more | |
Cipla Machine Operator Salary
0 - 8 years exp. (35 salaries) | ₹1.6 L/yr - ₹5.5 L/yr
54%
more | |
Login to view exact salary
| ||
Zydus Lifesciences Machine Operator Salary
1 - 8 years exp. (110 salaries) | ₹1 L/yr - ₹3.9 L/yr
16%
more | |
Lupin Machine Operator Salary
0 - 6 years exp. (44 salaries) | ₹1.1 L/yr - ₹6.5 L/yr
25%
more | |
Torrent Pharmaceuticals Machine Operator Salary
3 - 16 years exp. (4 salaries) | ₹2.1 L/yr - ₹6 L/yr
95%
more | |
Glenmark Pharmaceuticals Machine Operator Salary
0 - 4 years exp. (19 salaries) | ₹1.1 L/yr - ₹4.1 L/yr
31%
more | |
Aurobindo Pharma Machine Operator Salary
2 - 6 years exp. (26 salaries) | ₹1.8 L/yr - ₹5.5 L/yr
54%
more | |
DIVI'S Laboratories Machine Operator Salary
1 - 5 years exp. (4 salaries) | ₹1.4 L/yr - ₹2.7 L/yr
2%
more | |
Granules India Machine Operator Salary
0 - 4 years exp. (13 salaries) | ₹1 L/yr - ₹3.4 L/yr
1%
less | |
Gland Pharma Machine Operator Salary
0 - 4 years exp. (8 salaries) | ₹1.2 L/yr - ₹3 L/yr
3%
less | |
Biological E Machine Operator Salary
1 - 7 years exp. (6 salaries) | ₹2.2 L/yr - ₹4.8 L/yr
39%
more | |
Login to view exact salary
| ||
Flamingo Pharmaceuticals Machine Operator Salary
0 - 4 years exp. (5 salaries) | ₹1.5 L/yr - ₹3.9 L/yr
15%
more | 1 job opening |
Marksans Pharma Machine Operator Salary
2 - 5 years exp. (4 salaries) | ₹2.3 L/yr - ₹3.2 L/yr
38%
more | |
Sanofi Machine Operator Salary
1 - 10 years exp. (4 salaries) | ₹1.5 L/yr - ₹4.6 L/yr
37%
more | |
Piramal Pharma Machine Operator Salary
2 - 30 years exp. (4 salaries) | ₹5.2 L/yr - ₹5.4 L/yr
152%
more | |
Unichem Laboratories Machine Operator Salary
1 - 4 years exp. (3 salaries) | ₹1.5 L/yr - ₹3.5 L/yr
12%
more | |
Strides Pharma Machine Operator Salary
3 - 12 years exp. (3 salaries) | ₹3.3 L/yr - ₹9 L/yr
324%
more | |
Discover interview dos and don'ts from real experiences
Top trending discussions